Back

Extracellular volume is an independent predictor of peak cardiac power in asymptomatic patients with moderate-to-severe aortic stenosis

10 May 2023 (08:30 - 09:15)
Organised by:
Congress Presentation Part of: Aortic Stenosis 1 Extracellular Volume EACVI Premium Access EACVI 2023

About the speaker

Photo
Doctor Muhammad Haris

Glenfield Hospital, Leicester (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Right heart echocardiographic parameters and outcomes of patients with aortic stenosis after transcatheter aortic valve implantation
Doctor M. Brandao (Madrid, ES)
Abstract Slides
Presentation thumbnail
Optimal stroke volume index cut off for survival of severe aortic stenosis patients undergoing TAVI - where should we draw the line?
Mr D. Santos Ferreira (Vila Nova de Gaia, PT)
Abstract Slides
Presentation thumbnail
A novel approach in the assessment of paravalvular regurgitation after transcatheter aortic valve replacement using cardiac magnetic resonance imaging.
Mr M. Rooijakkers (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Do postoperative hemodynamic parameters add prognostic value for the prediction of mortality after surgical aortic valve replacement?
Mr B. Velders (Leiden, NL)
Abstract Slides
Presentation thumbnail
Supine ergometry induced changes of left ventricular function and pulmonary hypertension have an uneven prognostic relevance for asymptomatic aortic stenosis according to age and gender
Doctor I. Armenis (Nicosia, CY)
Abstract Slides

Access the full session

Session thumbnail
Aortic Stenosis 1

The Event

Event poster

EACVI 2023

10 May 2023 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Quantification of extracellular volume with cardiac computed tomography in patients with left ventricle dysfunction
thumbnail
Congress Presentation
Extra-cellular volume fraction analysis on cardiac CT is useful for predicting the prognosis of hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Comparative assessment of CMR-determined extracellular volume metrics in predicting adverse outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources